The NIH Loosens Grip on Gene Therapy Trials
The NIH Loosens Grip on Gene Therapy Trials
The agency proposes ceding its scrutiny of these studies to the FDA.
The NIH Loosens Grip on Gene Therapy Trials
The NIH Loosens Grip on Gene Therapy Trials

The agency proposes ceding its scrutiny of these studies to the FDA.

The agency proposes ceding its scrutiny of these studies to the FDA.

cancer, biotech, FDA
Elephants Revived a “Zombie” Gene that May Fend Off Cancer
Elephants Revived a “Zombie” Gene that May Fend Off Cancer
Kerry Grens | Aug 15, 2018
DNA damage kick-starts what was once a defunct duplicated gene, which kills off injured cells.
Jury Finds Monsanto’s Roundup Responsible for Man’s Cancer
Jury Finds Monsanto’s Roundup Responsible for Man’s Cancer
Sukanya Charuchandra | Aug 13, 2018
A San Francisco court levels $289 Million in damages against the pesticide maker.
Effort to Reproduce Cancer Studies Scales Down to 18 Papers
Effort to Reproduce Cancer Studies Scales Down to 18 Papers
Diana Kwon | Aug 1, 2018
The Reproducibility Project: Cancer Biology initially aimed to replicate the results of 50 high-impact research articles.
The Superpowers of Genetically Modified Pigs
The Superpowers of Genetically Modified Pigs
Kerry Grens | Aug 1, 2018
Scientists have engineered swine that pollute less, fend off disease, and produce more meat, but you won’t find them outside experimental farms . . . yet.
Opinion: Learning from Immunotherapy’s Recent Failures
Opinion: Learning from Immunotherapy’s Recent Failures
Luis Felipe Campesato | Aug 1, 2018
The promise of immunotherapy is real. We now need to figure out how to maximize the number of patients the approach benefits.
Third Retraction for Harvard Cancer Biologist
Third Retraction for Harvard Cancer Biologist
Katarina Zimmer | Jul 25, 2018
The move follows two major corrections to a 2011 Nature paper, in which researchers demonstrated that a natural compound selectively kills cancer cells.
Questions Raised About “Breakthrough” Therapies’ Clinical Support
Questions Raised About “Breakthrough” Therapies’ Clinical Support
Catherine Offord | Jul 17, 2018
Compared to other drugs, therapeutics given breakthrough status receive FDA approval on the basis of weaker trial evidence, a study finds.
Cancer Geneticist Quits After Harassment Allegations
Cancer Geneticist Quits After Harassment Allegations
Kerry Grens | Jul 17, 2018
Accusations that Nazneen Rahman bullied employees at the Institute of Cancer Research in the U.K. stretch back 12 years.
CRISPR Gene Editing Deletes, Shuffles More Genes than IntendedCRISPR Gene Editing Deletes, Shuffles More Genes than Intended
CRISPR Gene Editing Deletes, Shuffles More Genes than Intended
Ashley Yeager | Jul 16, 2018
The DNA-cutting enzyme used in the technique is not as precisely targeted as scientists had thought, and investors take notice.